1984 Volume 32 Issue Supplement2 Pages 292-294
TA-058, a new synthetic penicillin, was studied in respiratory tract infections and following results were obtained.
TA-058 was administered in 6 cases, 3 cases of pneumonia and 3 of chronic bronchitis, which were performed by drip infusion or intravenous injection of 1g, twice a day. Underlying diseases of these cases were chronic bronchitis and lung cancer.
The clinical efficacy was good in 4 cases and poor in 2 cases, and there were no side effects observed, nor any abnormal findings in the laboratory examinations.
Though we expected TA-058 to be effective in lower respiratory tract infection, it is necessary to use more dosis, according to these results in clinical efficacy and safety.